(Q33971345)

30 July 2017

1 reference

title

The role of complement in Alzheimer's disease pathology (English)

1 reference

30 July 2017

0 references

M R Emmerling

1

1 reference

30 July 2017

M D Watson

series ordinal

2

1 reference

30 July 2017

C A Raby

series ordinal

3

1 reference

30 July 2017

K Spiegel

series ordinal

4

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 July 2000

1 reference

Biochimica et Biophysica Acta

30 July 2017

published in

1 reference

30 July 2017

volume

1502

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

158-171

1 reference

Cerebromicrovascular pathology in Alzheimer's disease compared to normal aging

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

The role of complement and activated microglia in the pathogenesis of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Amyloid, the presenilins and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Evolution of amyloid: what normal protein folding may tell us about fibrillogenesis and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Oxidative alterations in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Inflammation and Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

What are the facts and artifacts of the pathogenesis and etiology of Alzheimer disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

The importance of inflammatory mechanisms in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Inflammation of the brain in Alzheimer's disease: implications for therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Alzheimer's beta-amyloid peptide 1-42 induces a phagocytic response in murine microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

The HHQK domain of beta-amyloid provides a structural basis for the immunopathology of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement biosynthesis in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

The role of the complement system in traumatic brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Soluble complement receptor 1 (sCR1) protects against experimental autoimmune myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Transgenic models to assess the pathogenic actions of cytokines in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Albumin and immunoglobulin in plasma and cerebrospinal fluid, and blood-cerebrospinal fluid barrier function in patients with dementia of Alzheimer type and multi-infarct dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

CSF in Alzheimer's disease. Studies on blood-brain barrier function and intrathecal protein synthesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

The integrity of the blood-brain barrier in Alzheimer's type and multi-infarct dementia evaluated by the study of albumin and IgG in serum and cerebrospinal fluid.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Local immunoglobulin synthesis and blood-brain barrier assessment in subacute sclerosing panencephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Production and interferon-gamma-mediated regulation of complement component C2 and factors B and D by the astroglioma cell line U105-MG

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Interferon-gamma regulation of C3 gene expression in human astroglioma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Expression of the receptors for the C5a anaphylatoxin, interleukin-8 and FMLP by human astrocytes and microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Characterization of rat C5a anaphylatoxin receptor (C5aR): cloning of rat C5aR cDNA and study of C5aR expression by rat astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement gene expression in mouse microglia and astrocytes in culture: comparisons with mouse peritoneal macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement mRNA in the mammalian brain: responses to Alzheimer's disease and experimental brain lesioning

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Cultured rat microglia express C1q and receptor for C1q: implications for amyloid effects on microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement C1qB and C4 mRNAs responses to lesioning in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement and cytokine gene expression in cultured microglial derived from postmortem human brains

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Synthesis and secretion of complement proteins by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Microglial cells around amyloid plaques in Alzheimer's disease express leucocyte adhesion molecules of the LFA-1 family

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Lesion of the rat entorhinal cortex leads to a rapid microglial reaction in the dentate gyrus. A light and electron microscopical study

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Axotomy of the rat facial nerve leads to increased CR3 complement receptor expression by activated microglial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Chemotaxis by a CNS macrophage, the microglia

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Selective expression of clusterin (SGP-2) and complement C1qB and C4 during responses to neurotoxins in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Neuronal expression of mRNAs for complement proteins of the classical pathway in Alzheimer brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Neurons express proteins of the classical complement pathway in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Up-regulated production and activation of the complement system in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement receptors CR1 on human peripheral nerve fibres

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement C5a anaphylatoxin fragment causes apoptosis in TGW neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement C1-inhibitor expression in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement C1 inhibitor is produced by brain tissue and is cleaved in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement regulatory protein expression by a human oligodendrocyte cell line: cytokine regulation and comparison with astrocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Role of complement in the aetiology of Pick's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Glycolipid-anchored proteins in neuroblastoma cells form detergent-resistant complexes without caveolin

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

A Monoclonal Antibody That Reacts Immunohistochemically with Amyloid Deposits in the Brain Tissue of Alzheimer Patients Binds to an Epitope Present on Complement Factor 4

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement activation in amyloid plaques in Alzheimer's disease brains does not proceed further than C3.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Early complement components in Alzheimer's disease brains.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Ultrastructural localization of complement membrane attack complex (MAC)-like immunoreactivity in brains of patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Amyloid and senile plaques and cerebral blood vessels. A semi-quantitative investigation of a possible relationship.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Acute phase proteins but not activated microglial cells are present in parenchymal beta/A4 deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Distribution of A beta-associated proteins in cerebrovascular amyloid of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Association cortex, cerebellum, and serum concentrations of C1q and factor B in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

The determination of the complement components C1q, C4 and C3 in serum and cerebrospinal fluid by radioimmunoassay

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Elevation of human cerebrospinal fluid clusterin concentration is associated with acute neuropathology.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

SP-40,40 is a constituent of Alzheimer's amyloid

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Brain expression of apolipoproteins E, J, and A-I in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Decreased levels of C1q in cerebrospinal fluid of living Alzheimer patients correlate with disease state

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Cerebrospinal fluid C3a increases with age, but does not increase further in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Clusterin (apolipoprotein J) protein levels are increased in hippocampus and in frontal cortex in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement inhibitor C4-binding protein in amyloid deposits containing serum amyloid P in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Detection of the membrane inhibitor of reactive lysis (CD59) in diseased neurons of Alzheimer brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Alzheimer's disease in Down's syndrome: clinicopathologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Transgenic mice for the amyloid precursor protein 695 isoform have impaired spatial memory

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Introduction and expression of the 400 kilobase amyloid precursor protein gene in transgenic mice [corrected]

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

The mouse C1q A-chain sequence alters beta-amyloid-induced complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement activation by beta-amyloid in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement interactions with amyloid β1–42: A nidus for inflammation in AD brains

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Pro-inflammatory complement activation by the A beta peptide of Alzheimer's disease is biologically significant and can be blocked by vaccinia virus complement control protein

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Inhibiting the formation of classical C3-convertase on the Alzheimer's beta-amyloid peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

The C-terminus of the beta protein is critical in amyloidogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Multivalent binding of complement protein C1Q to the amyloid beta-peptide (A beta) promotes the nucleation phase of A beta aggregation.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Enhanced aggregation and beta structure of amyloid beta peptide after coincubation with C1q.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Aspartate residue 7 in amyloid beta-protein is critical for classical complement pathway activation: implications for Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Enhanced cytotoxicity of amyloid beta-peptide by a complement dependent mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Complement-mediated neurotoxicity is regulated by homologous restriction.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Induced expression of neuronal membrane attack complex and cell death by Alzheimer's beta-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Enhanced pathologic properties of Dutch-type mutant amyloid beta-protein

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Pathologic amyloid beta-protein cell surface fibril assembly on cultured human cerebrovascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Effect of hog anaphylatoxin (C 5a) on vascular permeability and leukocyte emigration in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Mediation of increased vascular permeability after complement activation. Histamine-independent action of rabbit C5a

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Pharmacological studies of FUT-175, nafamstat mesilate. I. Inhibition of protease activity in in vitro and in vivo experiments.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Benzenesulfonamide derivatives of 2-substituted 4H-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

New opportunities in AD research--roles of immunoinflammatory responses and glia.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Support of homeostatic glial cell signaling: a novel therapeutic approach by propentofylline

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Differential regulation of microglial activation by propentofylline via cAMP signaling.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

HWA 285 (propentofylline)--a new compound for the treatment of both vascular dementia and dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Peripheral administration of novel anti-inflammatories can attenuate the effects of chronic inflammation within the CNS.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Nordihydroguaiaretic acid protects hippocampal neurons against amyloid beta-peptide toxicity, and attenuates free radical and calcium accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Brain trauma induces massive hippocampal neuron death linked to a surge in beta-amyloid levels in mice overexpressing mutant amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Neurotrophic and neuroprotective effects of hAPP in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

Clinical trial of indomethacin in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0925-4439%2800%2900042-9

7 January 2021

10.1016/S0925-4439(00)00042-9

Identifiers

DOI

1 reference

30 July 2017

1 reference